Search
Kestra Medical Technologies Ltd
KMTSAdd to Watchlist
22.830USD
-0.320-1.38%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.34BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Kestra Medical Technologies Ltd is 8.86, ranking 12 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 28.00, with a high of 32.00 and a low of 22.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
29.667
Target Price
+29.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Kestra Medical Technologies Ltd
KMTS
7
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Kestra Medical Technologies Ltd's expected revenue for the next quarter?
Kestra Medical Technologies Ltd's expected revenue is 29.01M.
What is Kestra Medical Technologies Ltd's price target?
Analysts forecast that Kestra Medical Technologies Ltd's price target is USD 28.00, with the highest forecast at USD 32.00 and the lowest forecast at USD 22.00.
How have Kestra Medical Technologies LtdKMTS's recent earnings per share performed?
The market expectation was USD -0.67, while Kestra Medical Technologies LtdKMTS's earnings per share (EPS) for the previous quarter was USD -0.61. EPS for the next quarter is expected at USD -0.62.
What is the analyst rating for Kestra Medical Technologies Ltd?
Based on the ratings of Kestra Medical Technologies Ltd's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.